Trial Profile
Study to investigate Transesophageal echocardiography (TEE) is necessary before AF ablation in patients treated with novel oral anticoagulants (NOACs).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 31 Jan 2018 New trial record